Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Improved glycemic control after long-term insulin pump use in pediatric patients with type 1 diabetes.

Scrimgeour L, Cobry E, McFann K, Burdick P, Weimer C, Slover R, Chase HP.

Diabetes Technol Ther. 2007 Oct;9(5):421-8.

PMID:
17931050
2.

Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control?

Shalitin S, Lahav-Ritte T, Lebenthal Y, Devries L, Phillip M.

Diabetes Technol Ther. 2012 May;14(5):389-97. doi: 10.1089/dia.2011.0267. Epub 2012 Jan 27.

PMID:
22283639
3.

Impact of insulin pump therapy on long-term glycemic control in a pediatric Spanish cohort.

Colino E, Martín-Frías M, Yelmo R, Álvarez MÁ, Roldán B, Barrio R.

Diabetes Res Clin Pract. 2016 Mar;113:69-76. doi: 10.1016/j.diabres.2016.01.012. Epub 2016 Feb 1.

PMID:
26972965
4.
5.

Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes.

Willi SM, Planton J, Egede L, Schwarz S.

J Pediatr. 2003 Dec;143(6):796-801.

PMID:
14657831
7.

Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report.

Weinzimer SA, Ahern JH, Doyle EA, Vincent MR, Dziura J, Steffen AT, Tamborlane WV.

Pediatrics. 2004 Dec;114(6):1601-5. Erratum in: Pediatrics. 2005 Feb;115(2):518.

PMID:
15574621
8.

Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes.

Alemzadeh R, Parton EA, Holzum MK.

Diabetes Technol Ther. 2009 Aug;11(8):481-6. doi: 10.1089/dia.2008.0124.

PMID:
19698060
9.

Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy.

Shalitin S, Gil M, Nimri R, de Vries L, Gavan MY, Phillip M.

Diabet Med. 2010 Mar;27(3):339-47. doi: 10.1111/j.1464-5491.2009.02925.x.

PMID:
20536498
10.

Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.

Alemzadeh R, Palma-Sisto P, Holzum M, Parton E, Kicher J.

Diabetes Technol Ther. 2007 Aug;9(4):339-47.

PMID:
17705689
11.

Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years.

Jakisch BI, Wagner VM, Heidtmann B, Lepler R, Holterhus PM, Kapellen TM, Vogel C, Rosenbauer J, Holl RW; German/Austrian DPV Initiative and Working Group for Paediatric Pump Therapy.

Diabet Med. 2008 Jan;25(1):80-5. doi: 10.1111/j.1464-5491.2007.02311.x.

PMID:
18199134
12.

Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care.

Maniatis AK, Klingensmith GJ, Slover RH, Mowry CJ, Chase HP.

Pediatrics. 2001 Feb;107(2):351-6.

PMID:
11158469
13.
14.

Beneficial effects of continuous subcutaneous insulin infusion in older patients with long-standing type 1 diabetes.

Rizvi AA, Petry R, Arnold MB, Chakraborty M.

Endocr Pract. 2001 Sep-Oct;7(5):364-9.

PMID:
11585372
15.
16.

Benefits of continuous subcutaneous insulin infusion (CSII) therapy in preschool children.

Levy-Shraga Y, Lerner-Geva L, Modan-Moses D, Graph-Barel C, Mazor-Aronovitch K, Boyko V, Pinhas-Hamiel O.

Exp Clin Endocrinol Diabetes. 2013 Apr;121(4):225-9. doi: 10.1055/s-0032-1331698. Epub 2013 Jan 17.

PMID:
23329580
17.
18.

Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial.

Weintrob N, Benzaquen H, Galatzer A, Shalitin S, Lazar L, Fayman G, Lilos P, Dickerman Z, Phillip M.

Pediatrics. 2003 Sep;112(3 Pt 1):559-64.

PMID:
12949284
19.

Efficacy of continuous subcutaneous insulin infusion in Type 1 diabetes: a 2-year perspective using the established criteria for funding from a National Health Service.

Giménez M, Conget I, Jansà M, Vidal M, Chiganer G, Levy I.

Diabet Med. 2007 Dec;24(12):1419-23. Epub 2007 Oct 17.

PMID:
17941861
20.

Supplemental Content

Support Center